Incisional Negative Pressure Wound Therapy for Prevention of Postoperative Infections Following Caesarean Section
Use of Incisional Negative Pressure Wound Therapy for Prevention of Postoperative Infections Following Caesarean Section in Women With BMI >=30
1 other identifier
interventional
876
1 country
5
Brief Summary
The purpose of this study is to examine whether obese women (BMI \>= 30) who give birth by caesarean section have a reduced incidence of wound infection and dehiscence when incisional Negative Pressure Wound Therapy is applied prophylactically following caesarean section.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2013
Typical duration for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 27, 2013
CompletedFirst Posted
Study publicly available on registry
July 2, 2013
CompletedStudy Start
First participant enrolled
September 10, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 13, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedJanuary 31, 2017
January 1, 2017
3.1 years
June 27, 2013
January 30, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The incidence of post-CS wound infection in each study group
Wound infection requiring antibiotic treatment To be able to collect information about symptoms of infection after discharge a self-administered questionnaire will be sent to all participants within 30 days post-CS. Furthermore data on postoperative infections, recorded by diagnoses codes or surgical procedures, will be obtained from the Danish National Patient Registry
Within the first 30 days after surgery
Secondary Outcomes (6)
Length of the primary and any secondary hospitalization
Within the first 30 days after Caesarean Section
Readmissions to hospital/contact to the general practitioner on suspicion of infection following caesarean section
Within the first 30 days after Caesarean Section
Number of Participants with a decreased health-related quality of life score as a measure of satisfaction and tolerability
Within the first 30 days after Caesarean Section
Antibiotic treatment on suspicion of infection after Caesarean Section
Within the first 30 days after Caesarean Section
The cosmetic outcome as a measure of satisfaction
A 6 and 12 months follow-up
- +1 more secondary outcomes
Study Arms (2)
iNPWT
EXPERIMENTALNegative Pressure Wound Therapy (NPWT) is a mechanical wound care treatment using controlled sub-atmospheric pressure to assist and accelerate wound healing. Incisional Negative Pressure Wound Therapy (iNPWT) is a new NPWT devices, which can be used over clean closed surgical incisions. The device behaves in a similar fashion to existing conventional NPWT devices, i.e. transmission of negative pressure levels at the wound bed, tissue contraction and establishing a characteristic pattern of peri-wound blood flow and that it reduces and normalises tissue stresses at the incision
Standard wound dressing
ACTIVE COMPARATORThe standard postoperative wound dressing is a normal wound dressing, used over clean closed incisions.
Interventions
The Incisional Negative Pressure Wound Therapy (iNPWT) will be applied over the clean closed incision immediately following the operation (caesarean section). In the intervention group the therapy will be left in situ for five days.
A standard wound dressing will be applied over the clean closed incision immediately following the operation (caesarean section). In the control group the dressing will be left in situ for at least 24 hours as standard procedure.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 year
- Women who can read and understand Danish
- pregestational BMI ≥ 30 kg/m2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Odense University Hospitallead
- Region of Southern Denmarkcollaborator
- University of Southern Denmarkcollaborator
- Hvidovre University Hospitalcollaborator
- Smith & Nephew, Inc.collaborator
Study Sites (5)
Aarhus University Hospital
Aarhus, Jutland, 8200, Denmark
Hospital South West Jutland
Esbjerg, Jutland, 6700, Denmark
Hospital Lillebaelt, Kolding Hospital
Kolding, Jutland, 6000, Denmark
Hvidovre Hospital
Hvidovre, 2650, Denmark
Odense University Hospital
Odense, 5000, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Nana Hyldig, PhD Student
Odense University Hospital, department of Plastic Surgery, University of Southern Denmark, Faculty of Health Sciences, institute of Clinical Research, research unit, department of Gynaecology and Obstetrics
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Student
Study Record Dates
First Submitted
June 27, 2013
First Posted
July 2, 2013
Study Start
September 10, 2013
Primary Completion
October 13, 2016
Study Completion
December 1, 2016
Last Updated
January 31, 2017
Record last verified: 2017-01
Data Sharing
- IPD Sharing
- Will not share